Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Primedic
Rigel Medical

Mesh Matrix Treats Hard-to-Heal Wounds

By HospiMedica International staff writers
Posted on 27 Feb 2014
Image: The MatriStem Multilayer Wound Matrix device is designed for deep, hard-to-heal wounds (Photo courtesy of ACell).
Image: The MatriStem Multilayer Wound Matrix device is designed for deep, hard-to-heal wounds (Photo courtesy of ACell).
A new multilayer matrix device accommodates moderate to heavy wound exudate and provides effective contouring functionality in wound treatment.

The MatriStem Multilayer Wound Matrix device is designed to maintain and support a healing environment through constructive tissue remodeling for both acute and chronic wounds. The device is comprised of naturally occurring urinary bladder matrix (UBM), the basement membrane of porcine urinary bladder tissue, which is disinfected, packaged, and sterilized to produce a non-cross-linked, completely resorbable, acellular extracellular matrix (ECM) scaffold that is rich with naturally occurring collagens and proteins.

UBM provides several distinguishable characteristics, including the recruitment of progenitor cells, chemotactic and mitogenic activities, and site-specific tissue remodeling. UBM also has the ability to facilitate the body’s own regenerative capabilities and help restore normal site-appropriate tissue while avoiding scar tissue formation; the ability to be used "off-the-shelf" and stored at room temperature, with an approximate two-year shelf life; and superior ease-of-use characteristics.

MatriStem is easy to prepare, apply, and fixate, and requires no special handling requirements. It is indicated for all types of wound management, including pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds, trauma wounds, and the reinforcement of soft tissue where weakness exists in urological, gynecological, and gastroenterological anatomy. The MatriStem Multilayer Wound Matrix device is a product of ACell (Columbia, MD, USA), and has been approved by the US Food and Drug Administration (FDA).

“ACell has developed MatriStem Multilayer Wound Matrix to address an unmet need in the area of acute and chronic wound care management,” said Jim DeFrancesco, CEO of ACell. “The launch of this new product provides a new option for physicians treating patients suffering from deep, hard-to-heal wounds.”

Related Links:

ACell



Channels

Women's Health

view channel

Tampons Could Help Predict Endometrial Cancer

A new study shows that vaginal secretions in tampons can be used to detect the presence of endometrial cancer DNA. Researchers at the Mayo Clinic (Rochester, MN, USA) obtained samples from 66 women who were about to undergo a hysterectomy, 38 of them due to endometrial cancer and 28 due to other indications.... Read more

Hospital News

view channel

Ventas to Buy Healthcare Services Provider Ardent

Healthcare real-estate investment trust (REIT) Ventas (Chicago, IL, USA) will buy hospital operator Ardent Medical Services (Nashville, TN, USA) for USD 1.75 billion in cash. Under the terms of the agreement, Ventas will own 10 hospital properties and will separate their operations into entities that will be owned by... Read more

Business

view channel
Image: Entrance to Medical Fair India 2015 (Photo courtesy of Boson Biotech).

Booming Health Market Benefits Medical Fair India

Over 10,400 international trade visitors attended Medical Fair India 2015, India’s premier trade fair for hospitals, health centers, and clinics. The 21st International Exhibition and Conference held... Read more
 

Events

27 Apr 2015 - 29 Apr 2015
28 Apr 2015 - 01 May 2015
05 May 2015 - 07 May 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.